Clinical Trials Browser

Prostatic Neoplasms × Sunitinib × 90 days × Clear all

NCT00329043 2025-12-26

Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy

Phase 2 Active not recruiting

Prostatic Neoplasms